Özet:

Aims: We conducted this study to investigate the clinical significance of lactate kinetics in patients admitted to the intensive care unit (ICU) for diabetic ketoacidosis (DKA). Methods: This retrospective study was conducted between November 1, 2016, and December 31, 2020. Serial lactate measurements (at the hospital admission, ICU admission, and in 24 hours periods until 48 hours of ICU stay) of the patients admitted to our ICU with a diagnosis of DKA were recorded. Results: Forty patients were included in the study (mean age: 50.6±19.4 years, female 60%). Eighty-five percent (n=34) of patients had increased (>2 mmol/L) blood lactate levels on admission. There was no significant difference between the low (lactate <4 mmol/L) and high-lactate (lactate ≥4 mmol/L) groups in mortality (p=0.195), ICU stay (p=0.966) and hospital length of stay (LOS) (p=0.274). However, the group with less than 40% decrease in lactate level from hospital admission to ICU had significantly higher Acute Physiology and Chronic Health Assessment II score [24 (12-46) vs. 18 (2-27), p=0.007], longer ICU stay [5 (1-40) vs. 3 (2-8) days, p=0.032], and higher mortality rate [6 (26.1) vs. 0 (0.0), p=0.030]. Additionally, non-survivors (n=6) had significantly higher lactate levels at hospital admission [3.0 (1.3-15.0) vs. 5.1 (3.9-13.5) mmol/L, p=0.017], and ICU admission [2.3 (0.6-9.4) vs. 5.0 (2.4-16.0) mmol/L, p=0.010] than survivors. Conclusions: Although the ICU LOS and mortality did not differ between initial high and lowlactate groups in the present study, the lactate kinetics, especially in the early treatment period, can guide referral to the ICU level of care and determine the DKA patients at higher risk of death.

Anahtar Kelimeler: